Sagimet Biosciences Inc.

Direct answer

Sagimet Biosciences Inc. is publicly traded on NASDAQ under the ticker SGMT.

Sagimet Biosciences Inc. is a biopharmaceutical company with drug candidates in clinical trials, specializing in developing therapies that target fatty acid synthase (FASN) inhibition. These treatments are engineered to combat medical conditions stemming from impaired lipid metabolism pathways. Its primary investigational compound, Denifanstat, is a FASN inhibitor currently being evaluated for nonalcoholic...

Can you invest in Sagimet Biosciences Inc.?

Yes. Sagimet Biosciences Inc. trades publicly on NASDAQ as SGMT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Sagimet Biosciences Inc.

Detailed equity research is provided by MarketSnap.